Closed-Loop Insulin Infusion Mode Switching With User Alerts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing insulin infusion systems lack user-configurable notification and control mechanisms that allow for safe regulation of blood glucose levels without disrupting daily activities, particularly during overnight use.

Innovation Solution

A system that includes user-configurable notifications and closed-loop control, allowing users to switch between modes based on their preferences, receive personalized alerts, and adjust infusion device operations through user input, with adaptive responses to detected alert conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If closed-loop control is implemented to autonomously regulate blood glucose levels, then control precision and safety are improved, but device complexity and user interaction requirements increase

Engineering Contradiction:
Improveblood glucose level control precisionVSAvoidcontrol system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The control system is segmented into distinct operational modes (manual mode and automated mode), allowing the system to function autonomously when needed while simplifying user interaction when preferred. This segmentation resolves the contradiction by enabling precise control without requiring the user to constantly manage complex settings.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system dynamically transitions between operational modes based on user input and physiological conditions. The infusion pump can switch between manual control and automated closed-loop control, adapting the level of automation to match user preferences and situational needs, thereby balancing control precision with operational simplicity.

Inventive Principle:
Principle #15Dynamics

2Reliability

If continuous autonomous insulin infusion is provided, then blood glucose regulation effectiveness is improved, but user awareness and control capability deteriorate

Engineering Contradiction:
Improveblood glucose regulation effectivenessVSAvoiduser control capability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system provides dynamic control where users can adjust the level of autonomy in real-time. Users retain the ability to override automated decisions, manually adjust infusion rates, and switch between control modes, ensuring they maintain awareness and control capability while benefiting from automated regulation when desired.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The closed-loop system continuously monitors blood glucose levels and provides feedback to both the control algorithm and the user through notifications and alerts. This feedback mechanism ensures users remain informed about their physiological state and system actions, maintaining user awareness while achieving effective autonomous regulation.

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If automated mode switching is implemented, then adaptability to user preferences is improved, but device complexity and notification management increase

Engineering Contradiction:
Improvemode switching adaptabilityVSAvoidnotification system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The notification system serves multiple functions: it informs users of mode transitions, alerts users to physiological conditions, provides system status updates, and delivers actionable recommendations. This multi-functionality allows the system to be highly adaptable to user preferences without proportionally increasing complexity, as a single notification infrastructure handles diverse communication needs.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12496397B2User-configurable closed-loop notifications and infusion systems incorporating same
Publication Date: 2025.12.16 MEDTRONIC MINIMED INC
  • US12496397B2 patent drawing
  • US12496397B2 patent drawing
  • US12496397B2 patent drawing

AI summary

A system includes one or more processors, and one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of: switching operation of an infusion device from a first mode of fluid delivery to a second mode of fluid delivery, the first mode being different from the second mode, receiving user input after the infusion device is operating in the second mode, the user input being indicative of whether the infusion device should remain operating in the second mode or transition from the second mode to a different mode, and operating the infusion device in a manner that is influenced by the user input.